BioMarin Pharmaceutical | BMRN - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2025 1.49 0.12 Nov/03
FY2026Q2 Jun/2026 1.20 0.95 1.44 Aug/06
FY2026Q1 Mar/2026 0.76 0.74 1.13 May/04
FY2025Q4 Dec/2025 0.46 0.77 0.92 Feb/23
FY2025Q3 Sep/2025 0.12 0.86 0.91 Oct/27




Eps Alterar Data
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amgen USD 6.29 1.14 2026-06
Bayer EUR 0.95 1.76 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
Incyte USD 3.09 1.28 2026-06
Insmed USD -0.06 0.7 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Moderna USD -1.97 1.43 2026-06
Neurocrine Biosciences USD 2.85 0.91 2026-06
PTC Therapeutics USD 0.92 0.95 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Roche Holding CHF 10.98 2.61 2026-06
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 2.17 2.84 2026-03
Sarepta Therapeutics USD 0.64 2.52 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
United Therapeutics USD 7.27 1.45 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06